Roswell Biotechnologies to Present First Commercial Molecular Electronics Chip at the 2022 International Solid-State Circuits Conference

The paper presentation and demo demo platforms highlight a new kind of chip that integrates molecular electronics as a scalable, programmable biosensor

SAN – DIEGO, February 16, 2022 / PRNewswire / – Roswell Biotechnologiesmolecular electronics company, announced today that the chief scientific officer Barry Meriman, Ph.D. to present a report entitled “CMOS Molecular Electronics Chip for Monomolecular Biosensor” at the prestigious International Conference on Solid State Circuits (ISSCC) on February 22. The presentation will detail the design of Roswell Molecular Electronics (ME) Chip ™, the first commercial molecular electronics chip. Roswell’s molecular electronics platform was also chosen for a highly selective live demo session conference.

Roswell Molecular Electronics Chip ️ ️, the first commercial molecular electronics chip, combines individual biomolecules as sensory elements in nanoelectrode circuits on a semiconductor (CMOS) chip. It provides a fully electronic programmable biosensor with sensitivity to a single molecule in real time and unlimited ability to scale the density of the sensor array.

The Roswell ME chip combines individual biomolecules as sensor elements in nanoelectrode circuits on a semiconductor (CMOS) chip. It provides a fully electronic programmable biosensor with sensitivity to a single molecule in real time and unlimited ability to scale the density of the sensor array. A a peer-reviewed work has recently appeared y Proceedings of the National Academy of Sciences details of its diverse biosensing applications.

“It is a great honor that our molecular electronics chip was recognized at this conference as one of the most innovative new chips,” Merriman said. “ISSSCC is a place where leading chipmakers such as Intel, Samsung and NVIDIA present their latest work and introduce the most exciting new chips, such as the Intel Bitcoin mining chip and the Google Quantum computing chip. Our peer-reviewed document and demo together with these leading chipmakers emphasize that we are doing something truly new by integrating individual molecules into circuits as sensors. ”

The presentation and demonstration of the Roswell ME Chip document will be available to registered conference attendees online, in recorded form, as the ISSCC is held virtually this year due to the pandemic. After the conference, the peer-reviewed paper will be published in IEEE Xplore, the IEEE online library.

The IEEE-sponsored annual ISSCC is a major global forum for presenting advances in solid-state circuits and systems on a chip. The conference offers a unique opportunity for engineers working on advanced IC design and application to maintain technical currency and communicate with leading experts.

ABOUT ROSWELL BIOTECHNOLOGIES
Roswell Biotechnologies digitizes biology using molecular electronics to predict, prevent and treat disease. The company has developed the world’s first molecular electronics chip Roswell ME Chip ™, which combines individual molecules into a standard semiconductor chip. It provides a programmable biosensor that integrates a wide range of biosensing and omics measurement applications on a single platform, provides the highest real-time sensing separation of a single molecule and removes all barriers to chip scalability. Roswell’s molecular electronics platform is commercialized for basic biomedical research, drug discovery, molecular diagnostics, proteomics, DNA sequencing, and digital DNA data storage. Roswell Biotechnologies was founded in 2014 by industry leaders in genomic technology and is headquartered in San Diego, CA..

(PRNewsfoto / Roswell Biotechnologies, Inc.)

(PRNewsfoto / Roswell Biotechnologies, Inc.)

Cision

Cision

See original multimedia download content: https://www.prnewswire.com/news-releases/roswell-biotechnologies-to-present-first-commercial-molecular-electronics-chip-at-the-2022-international-solid-state -schemes-conference-301484057.html

SOURCE Roswell Biotechnologies, Inc.

Leave a Comment